N/A N=42 Developing an Online Therapeutic Intervention for Chronic Pain in Veterans
Chronic Pain
Primary: System Usability Scale (SUS) — 79.6 score on a scale
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=11 Interleukin-1 Trap to Treat Autoinflammatory Diseases
Inflammation · Familial Mediterranean Fever · Still's Disease, Adult-Onset
Primary: Mean Change in Daily Scores — -3.09 units on a scale
N/A N=60 Comparison Effects Of Different Exercise Approaches On Type 2 DM Women
Type 2 Diabetes
Primary: Glycosylated Hemoglobin Change — 6.82; 7.17; 6.80; 6.33 percentage of glycosylated hemoglobin — p=0.830
Phase 2 N=58 A Study to Assess the Efficacy, Safety, and Tolerability of KPL-716 in Reducing Pruritus in Chronic Pruritic Diseases
Chronic Idiopathic Urticaria · Chronic Idiopathic Pruritus · Lichen Planus
Primary: Change From Baseline in Weekly Average WI-NRS at Week 8 — -4.3; -1.1; -4.3; -3.7 score on a scale — p=0.3980
Phase 1 N=23 Fecal Microbiota Transplantation in Pediatric Patients
Inflammatory Bowel Diseases (IBD) · Crohn's Disease (CD) · Ulcerative Colitis (UC)
Primary: Number of Occurrences of Adverse Events at 6 Months According to Adverse Event Term — 11; 5; 5; 3 Events
N/A N=350,399 A Study To Learn About The Effects Of Pneumococcal Vaccine In People With HIV
HIV · Pneumonia · Infections, Pneumococcal
Primary: PCV13 Vaccine Effectiveness (VE) for First Event of Invasive Pneumococcal Disease (IPD): Overall Follow-up — 167; 747 Participants
Phase 2 N=18 Anakinra for Inflammatory Pustular Skin Diseases
Sneddon-Wilkinson · Acrodermatitis Continua of Hallopeau · Pustular Psoriasis
Primary: Number of Participants Treated With Anakinra Who Achieve 50% Disease Improvement by the End of Week 12, as Measured by Total Body Surface Area Involvement (TBSAI50) — 7…
Phase 2 N=200 Safety and Efficacy of Xenical in Children and Adolescents With Obesity-Related Diseases
Diabetes Mellitus · Hypertension · Metabolic Disease
Primary: Change in BMI Standard Deviation Score — -0.12; -0.06 Standard Deviation Score — p=0.007
N/A N=72 PET-MRI in Diagnosing Patients With Cancer, Cardiac Diseases, or Neurologic Diseases
Cardiac Disease · Dementia · Inflammatory Disease
Primary: Overall Image Quality Scores
N/A N=500 Greek Study on Work Productivity and Sleep in Patients With Rheumatic Diseases Treated With Adalimumab
Rheumatoid Arthritis · Ankylosing Spondylitis · Psoriatic Arthritis
Primary: Mean Change From Baseline in Work Time Missed Due to Health Problem — 21.0; -18.9 Impairment percentage
N/A N=335 Vaccination Education Through Pharmacists and Senior Centers (VEPSC)
Infectious Disease · Pneumonia, Bacterial · Influenza
Primary: Mean Change in Knowledge and Awareness About Vaccine-Preventable Diseases — 3.5; 4.9; 1.3; 1.8 Scores on a scale — p=0.0081
N/A N=306 SToRytelling to Improve DiseasE Outcomes in GOut: The STRIDE-GO2 Study
Gout · Low Medication Adherence · Health Related Quality of Life
Primary: Medication Adherence — 72.61; 70.12; 68.52; 69.33 percentage of days ULT was taken
N/A N=23 Watermelon Focused Dietary Inflammatory Index Intervention
Inflammation · Diet Modification
Primary: Change in C-reactive Protein — -0.04; -0.56 mg/L
Phase 1 N=48 Whole Blood Platelet Aggregation in Chronic Kidney Disease Patients on Aspirin Study
Chronic Kidney Disease
Primary: Whole Blood Platelet Aggregation to 0.5 Millimoles Arachidonic Acid — 21.0; 18.0; 0; 0 ohms
N/A N=328 Chronic Pain Skills Study
Chronic Pain
Primary: Change From Pre-Treatment in Average Pain Intensity on a 0-10 Numerical Rating Scale Immediately Following End of Treatment (Post-Treatment) — -.57; -.61; -.85 score on…